Your browser doesn't support javascript.
loading
Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
Wang, Jianpeng; Li, Xishan; Wang, Fengjie; Shi, Degang; Zhang, Jiren.
Afiliação
  • Wang J; Department of Oncology, First People's Hospital of Foshan, Foshan Hospital of Sun Yat-Sen University, Foshan, China.
  • Li X; Department of Interventional Radiology, Guangzhou First People's Hospital, The Second Affiliated Hospital of South China University of Technology, Guangzhou, China.
  • Wang F; Department of Oncology, First People's Hospital of Foshan, Foshan Hospital of Sun Yat-Sen University, Foshan, China.
  • Shi D; Department of Oncology, First People's Hospital of Foshan, Foshan Hospital of Sun Yat-Sen University, Foshan, China.
  • Zhang J; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
J Cancer Res Ther ; 17(3): 619-624, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34269290

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Quimioembolização Terapêutica / Ablação por Cateter / Carcinoma Hepatocelular / Trombose Venosa / Indóis / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Quimioembolização Terapêutica / Ablação por Cateter / Carcinoma Hepatocelular / Trombose Venosa / Indóis / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article